116 related articles for article (PubMed ID: 11781823)
1. Increased susceptibility to tumorigenesis of ski-deficient heterozygous mice.
Shinagawa T; Nomura T; Colmenares C; Ohira M; Nakagawara A; Ishii S
Oncogene; 2001 Dec; 20(56):8100-8. PubMed ID: 11781823
[TBL] [Abstract][Full Text] [Related]
2. The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.
Shinagawa T; Dong HD; Xu M; Maekawa T; Ishii S
EMBO J; 2000 May; 19(10):2280-91. PubMed ID: 10811619
[TBL] [Abstract][Full Text] [Related]
3. Viral ski inhibits retinoblastoma protein (Rb)-mediated transcriptional repression in a dominant negative fashion.
Tokitou F; Nomura T; Khan MM; Kaul SC; Wadhwa R; Yasukawa T; Kohno I; Ishii S
J Biol Chem; 1999 Feb; 274(8):4485-8. PubMed ID: 9988677
[TBL] [Abstract][Full Text] [Related]
4. Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor.
Nomura T; Khan MM; Kaul SC; Dong HD; Wadhwa R; Colmenares C; Kohno I; Ishii S
Genes Dev; 1999 Feb; 13(4):412-23. PubMed ID: 10049357
[TBL] [Abstract][Full Text] [Related]
5. Ski co-repressor complexes maintain the basal repressed state of the TGF-beta target gene, SMAD7, via HDAC3 and PRMT5.
Tabata T; Kokura K; Ten Dijke P; Ishii S
Genes Cells; 2009 Jan; 14(1):17-28. PubMed ID: 19032343
[TBL] [Abstract][Full Text] [Related]
6. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
7. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
8. Protooncogene Ski cooperates with the chromatin-remodeling factor Satb2 in specifying callosal neurons.
Baranek C; Dittrich M; Parthasarathy S; Bonnon CG; Britanova O; Lanshakov D; Boukhtouche F; Sommer JE; Colmenares C; Tarabykin V; Atanasoski S
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3546-51. PubMed ID: 22334647
[TBL] [Abstract][Full Text] [Related]
9. Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.
Wang P; Chen Z; Meng ZQ; Fan J; Luo JM; Liang W; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Xu ZD; Liu LM
Carcinogenesis; 2009 Sep; 30(9):1497-506. PubMed ID: 19546161
[TBL] [Abstract][Full Text] [Related]
10. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
11. The Ski proto-oncogene regulates body composition and suppresses lipogenesis.
Leong GM; Kee AJ; Millard SM; Martel N; Eriksson N; Turner N; Cooney GJ; Hardeman EC; Muscat GE
Int J Obes (Lond); 2010 Mar; 34(3):524-36. PubMed ID: 20029376
[TBL] [Abstract][Full Text] [Related]
12. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
Heider TR; Lyman S; Schoonhoven R; Behrns KE
Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts.
Jinnin M; Ihn H; Mimura Y; Asano Y; Tamaki K
Arthritis Rheum; 2007 May; 56(5):1694-705. PubMed ID: 17469184
[TBL] [Abstract][Full Text] [Related]
14. Structure and activities of the ski oncogene.
Colmenares C; Stavnezer E
Semin Cancer Biol; 1990 Dec; 1(6):383-7. PubMed ID: 2103510
[TBL] [Abstract][Full Text] [Related]
15. The protooncogene Ski controls Schwann cell proliferation and myelination.
Atanasoski S; Notterpek L; Lee HY; Castagner F; Young P; Ehrengruber MU; Meijer D; Sommer L; Stavnezer E; Colmenares C; Suter U
Neuron; 2004 Aug; 43(4):499-511. PubMed ID: 15312649
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta suppresses the ability of Ski to inhibit tumor metastasis by inducing its degradation.
Le Scolan E; Zhu Q; Wang L; Bandyopadhyay A; Javelaud D; Mauviel A; Sun L; Luo K
Cancer Res; 2008 May; 68(9):3277-85. PubMed ID: 18451154
[TBL] [Abstract][Full Text] [Related]
17. Hemizygous disruption of Cdc25A inhibits cellular transformation and mammary tumorigenesis in mice.
Ray D; Terao Y; Nimbalkar D; Hirai H; Osmundson EC; Zou X; Franks R; Christov K; Kiyokawa H
Cancer Res; 2007 Jul; 67(14):6605-11. PubMed ID: 17638870
[TBL] [Abstract][Full Text] [Related]
18. c-Ski activates MyoD in the nucleus of myoblastic cells through suppression of histone deacetylases.
Kobayashi N; Goto K; Horiguchi K; Nagata M; Kawata M; Miyazawa K; Saitoh M; Miyazono K
Genes Cells; 2007 Mar; 12(3):375-85. PubMed ID: 17352741
[TBL] [Abstract][Full Text] [Related]
19. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
